CPP will be exhibiting at the Ohio AAP Annual Meeting on September 21st. Visit us in the vendor area at the Crowne Plaza in Dublin, OH!
The Immunization Action Coalition has put together a helpful guide for influenza vaccination coding for the 2018-2019 flu season. Doses are starting to be shipped out by the vaccine manufacturers so make sure you are ready to start vaccinating by having the appropriate CPT and Medicare codes in your system!
CPP is pleased to announce a new partnership with Dynavax, the manufacturer of the newly approved adult hepatitis-B vaccine Heplisav-B® administered as a 2-dose series. (April 2018 MMWR publication of the ACIP recommendation)
Members of CPP who opt-into the Dynavax contract can access discounted pricing on doses of Heplisav-B® purchased through an authorized distributor. For a complete list of authorized distributors, see attached list or call 1-84-HEPLISAV (1-844-375-4728).
Members who are interested in participating in the CPP/Dynavax contract should contact the CPP office at 614-722-2145 or firstname.lastname@example.org to obtain an opt-in form.
If you have any questions, please don’t hesitate to contact us!
Sanofi Pasteur hosted a webinar in April entitled Vaccine Confidence: The Key to Communicating with Parents and Patients. A recording of the webinar, which was attended by over 600 medical professionals, is now available to you on-demand. Speakers include Gary S. Marshall, MD from the University of Louisville School of Medicine and Carole H. Moloney, RN, MSN, CPNP from Boston Medical Center.
Simply go to http://vacadvwebcast2017.prihcs.com to register.
For the upcoming 2018-2019 flu vaccination season, the American Academy of Pediatrics is advising parents to choose the flu shot.
In February 2018, ACIP decided to make LAIV4 available for the 2018-2019 flu season, based on indirect study data from the manufacturer suggesting their new formulation would be effective, as well as a review of other published research.
However, upon review of the same data, the AAP recommends children receive the injectable form of the vaccine, which was shown to be more consistently effective against most strains of the flu virus over the past several flu seasons. For those children who would otherwise receive no flu vaccine, the AAP says the nasal spray vaccine can be given as a last resort, though it could leave them at higher risk for flu than if they had received the flu shot.
AAP will publish its formal policy statement on flu prevention and treatment in September.
Pfizer has announced an upcoming webinar to help you understand more meningococcal B disease and vaccination efforts.
The following dates and times are available for registration:
- Thursday, May 10, 2018 at 12:15PM ET
- Thursday, May 10, 2018 at 1:15PM ET
- Thursday, May 10, 2018 at 3:15PM ET
If you are interested in attending, log onto www.serogroupbmeeting.com and enter the access code: SCHEDULE to select a time that works for you.
Sanofi Pasteur will be hosting a webinar entitled:
Influenza Immunization: Helping to Prevent Disease in Adults 50 Years of Age and Older
The webcast will be offered within a 60-minute timeframe, which includes a 30-minute formal presentation plus a 30-minute live question-and-answer session. Sessions will be offered on the following dates and times:
|Tue, April 17||Dr. Robert Belshe||12:00 PM||11:00 AM||10:00 AM||9:00 AM|
|Tue, April 17||Dr. Robert Belshe||2:00 PM||1:00 PM||12:00 PM||11:00 AM|
|Wed, April 18||Dr. John Russell||1:00 PM||12:00 PM||11:00 AM||10:00 AM|
|Wed, April 18||Dr. John Russell||3:00 PM||2:00 PM||1:00 PM||12:00 PM|
For additional details about this program and to register, please click on the link below.